Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9084950 | 0.82 | LMNA (0.32) | LMNA | |
| SCHEMBL5269252 | 0.82 | — | — | |
| SCHEMBL1118354 | 0.78 | LPAR3 (0.44) | LPAR3LPAR2TSHRTRPA1ALDH1A1 | |
| SCHEMBL34470893 | 0.78 | LPAR3 (0.44) | LPAR3LPAR2TSHRTRPA1ALDH1A1 | |
| SCHEMBL5269630 | 0.77 | — | — | |
| SCHEMBL1118373 | 0.76 | LPAR3 (0.41) | LPAR3LPAR2TSHRTRPA1ALDH1A1 | |
| SCHEMBL5831832 | 0.75 | LMNA (0.33) | LMNA | |
| SCHEMBL29132605 | 0.75 | CES1 (0.44) | LPAR3LPAR2TSHRMAPT | |
| SCHEMBL9551594 | 0.75 | LPAR3 (0.41) | LPAR3LPAR2TSHRTRPA1ALDH1A1 | |
| SCHEMBL18528345 | 0.73 | LPAR3 (0.37) | LPAR3LPAR2TSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-09-01 | — | — | US | disclosed |
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-10-01 | — | — | US | disclosed |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-04-13 | — | — | US | disclosed |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | FFAR3, FFAR1, FAU | LPAR3 84/4885LPAR2 157/4885TSHR 1016/4885 |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | FFAR3, FFAR1, FAU | LPAR3 84/4885LPAR2 157/4885TSHR 1016/4885 |
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | PFN1, FFAR1, FAU | LPAR3 169/4885LPAR2 200/4885TSHR 1632/4885 |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | PFN1, FFAR1, FAU | LPAR3 169/4885LPAR2 200/4885TSHR 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.